Genetic variants in combination with early partial improvement as a clinical utility predictor of treatment outcome in major depressive disorder: the result of two pooled RCTs

by Kato, M, Serretti, A, Nonen, S, Takekita, Y, Wakeno, M, Azuma, J, Kinoshita, T
Published 2015

Neuropsychological Evaluation and Cerebral Blood Flow Effects of Apolipoprotein E4 in Alzheimer's Disease Patients after One Year of Treatment: An Exploratory Study

by Suwa, Azusa, Nishida, Keiichiro, Utsunomiya, Keita, Nonen, Shinpei, Yoshimura, Masafumi, Takekita, Yoshiteru, Wakeno, Masataka, Tajika, Aran, Yoshino, Maki, Koshikawa, Yosuke, Kato, Masaki, Kinoshita, Toshihiko
Published 2015

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response

by Biernacka, J M, Sangkuhl, K, Jenkins, G, Whaley, R M, Barman, P, Batzler, A, Altman, R B, Arolt, V, Brockmöller, J, Chen, C H, Domschke, K, Hall-Flavin, D K, Hong, C J, Illi, A, Ji, Y, Kampman, O, Kinoshita, T, Leinonen, E, Liou, Y J, Mushiroda, T, Nonen, S, Skime, M K, Wang, L, Baune, B T, Kato, M, Liu, Y L, Praphanphoj, V, Stingl, J C, Tsai, S J, Kubo, M, Klein, T E, Weinshilboum, R
Published 2015